Bcl9l - BCL9 like Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 300673
Summary
Predicted to enable beta-catenin binding activity. Predicted to be involved in several processes, including canonical Wnt signaling pathway; negative regulation of transforming growth factor beta receptor signaling pathway; and positive regulation of epithelial to mesenchymal transition. Predicted to act upstream of or within skeletal muscle cell differentiation and somatic stem cell population maintenance. Predicted to be located in nucleolus and nucleoplasm. Predicted to be part of beta-catenin-TCF complex. Orthologous to human BCL9L (BCL9 like). [provided by Alliance of Genome Resources, Apr 2022]
Bcl9l Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001106817.1 | NP_001100287.1 | B-cell CLL/lymphoma 9-like protein |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
B-cell CLL/lymphoma 9-like protein |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01444 | BCL9L Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21497 | Bcl9l Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28015 | Bcl9l Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service